LAM
VKTX icon

Lewis Asset Management’s Viking Therapeutics VKTX Stock Holding History

Lewis Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
64,090
+2,200
+4% +$70.7K 0.85% 30
2025
Q4 		$2.18M Buy
61,890
+5,960
+11% +$211K 0.89% 28
2025
Q3 		$1.47M Buy
55,930
+11,870
+27% +$354K 0.6% 40
2025
Q2 		$1.17M Buy
44,060
+385
+0.9% +$10.1K 0.55% 45
2025
Q1 		$1.05M Buy
43,675
+2,400
+6% +$75.9K 0.87% 26
2024
Q4 		$1.66M Buy
41,275
+10,880
+36% +$620K 1.27% 19
2024
Q3 		$1.92M Buy
30,395
+3,950
+15% +$232K 1.4% 15
2024
Q2 		$1.4M Buy
26,445
+10,320
+64% +$676K 1.07% 19
2024
Q1 		$1.32M Buy
+16,125
New +$717K 1.09% 18

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return